Form D · Biotechnology
Microbiome Insights Inc.
Vancouver, A1 · CIK 0001657948
Offering snapshot reported Mar 27, 2019 · SEC filing
- Reported sold
- $116K Offering amount: $389K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 25, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 27, 2019 | Initial | $115,978 | No comparison | 4 | SEC filing |
| Aug 16, 2017 | Initial | $167,813 | No comparison | 4 | SEC filing |
| Nov 10, 2015 | Initial | $18,927 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-335762
THE ADDITIONAL $272,986 MAY BE RECEIVED UPON THE EXERCISE OF SHARE PURCHASE WARRANTS SOLD INSIDE AND OUTSIDE THE U.S. U.S. DOLLAR AMOUNTS ARE BASED ON THE BANK OF CANADA AVERAGE RATE OF EXCHANGE REPORTED ON JANUARY 25, 2019, WHICH WAS CDN$1.3256=USD$1.00.
EACH UNIT IS COMPRISED OF ONE COMMON SHARE AND ONE-HALF OF ONE COMMON SHARE PURCHASE WARRANT. EACH WARRANT IS EXERCISABLE FOR ONE COMMON SHARE AT AN EXERCISE PRICE OF CDN$2.00 PER SHARE FOR A PERIOD OF 36 MONTHS.
Source: Form D, filed Mar 27, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pieter Cooper Cullis | Director |
| Mike Fannon | Director |
| Michael R. Fannon | Director |
| B. Brett Finlay | Executive |
| Barton Brett Finlay | Director, Executive |
| Malcolm Cooper Kendall | Director, Executive |
| Bill Mohn | Executive |
| William Wheeler Mohn | Director, Executive |
| Bradley Popovich | Director |
| Brad Popovich | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
595 Burrard Street, Suite 2600
Vancouver, A1, V7X 1L3
Vancouver, A1, V7X 1L3